A detailed history of Group One Trading, L.P. transactions in Enlivex Therapeutics Ltd. stock. As of the latest transaction made, Group One Trading, L.P. holds 5,730 shares of ENLV stock, worth $5,844. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,730
Previous 5,749 0.33%
Holding current value
$5,844
Previous $8,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.2 - $1.69 $22 - $32
-19 Reduced 0.33%
5,730 $9,000
Q2 2024

Aug 14, 2024

SELL
$1.27 - $4.31 $1,873 - $6,357
-1,475 Reduced 20.42%
5,749 $8,000
Q1 2024

May 10, 2024

BUY
$2.54 - $4.3 $18,348 - $31,063
7,224 New
7,224 $27,000
Q2 2023

Aug 09, 2023

SELL
$2.51 - $3.71 $31,121 - $46,000
-12,399 Reduced 91.85%
1,100 $2,000
Q4 2022

Feb 09, 2023

BUY
$3.74 - $4.81 $48,676 - $62,602
13,015 Added 2689.05%
13,499 $53,000
Q3 2022

Nov 09, 2022

SELL
$4.11 - $5.87 $9,864 - $14,088
-2,400 Reduced 83.22%
484 $2,000
Q2 2022

Aug 11, 2022

SELL
$3.81 - $8.64 $74,999 - $170,078
-19,685 Reduced 87.22%
2,884 $13,000
Q1 2022

May 12, 2022

BUY
$4.92 - $6.66 $111,039 - $150,309
22,569 New
22,569 $126,000

Others Institutions Holding ENLV

About Enlivex Therapeutics Ltd.


  • Ticker ENLV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,403,200
  • Market Cap $18.8M
  • Description
  • Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2...
More about ENLV
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.